Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-16

Clinical Trial Update: Prednisone for Heart Failure Patients With Hyperuricemia [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial explored prednisone for patients with heart failure and hyperuricemia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREDNISONE (Prednisone)

Snippet

Sponsor: Hebei Medical University | Conditions: Heart Failure, Hyperuricemia | Phase 2, Phase 3 | Status: COMPLETED